Skip to content

Ziprasidone oral capsules

DRUG7 trials

Sponsors

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Conditions

Bipolar DisorderSchizophrenia

Phase 3

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
CompletedNCT00257166
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Bipolar Disorder
Start: 2006-01-31End: 2007-07-31Updated: 2021-03-03
Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia
TerminatedNCT00257192
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Schizophrenia
Start: 2006-04-30End: 2009-03-31Updated: 2021-03-25
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
TerminatedNCT00265382
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Schizophrenia
Start: 2006-06-30End: 2009-06-30Updated: 2021-03-03
Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)
CompletedNCT00265330
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Bipolar Disorder
Start: 2006-03-31End: 2008-01-31Updated: 2021-03-25
Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)
WithdrawnNCT01117220
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Bipolar Disorder
Start: 2010-06-30End: 2011-04-30Updated: 2021-02-21
Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)
WithdrawnNCT01124877
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Bipolar Disorder
Start: 2010-07-31End: 2011-10-31Updated: 2021-02-21
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
TerminatedNCT02075047
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.Bipolar Disorder
Start: 2014-05-23End: 2020-05-18Updated: 2021-06-16

Related Papers